In principle, these distinct entry points could produce additive AMPK activation, but this dual activation has not been formally studied in humans and warrants physician oversight, particularly regarding blood glucose monitoring
Your options include switching to a different GLP-1 medication (tirzepatide acts on multiple hormone pathways, which may work better for some people who don't respond to other medications), asking a specialist to check for underlying metabolic or hormone issues, or trying combination approaches that pair medication with structured behavioral support
Qu son los agonistas del GLP-1
Semin Cell Dev Biol 144:4154
People who experienced gastric and intestinal conditions, blood clots, vision loss, and other severe complications from Ozempic may still be able to file a lawsuit to seek compensation for their injuries